Detailed insights into breast lesion localization market

Breast lesions are abnormal changes in the breast tissue brought on by diseases, injuries, or hereditary problems. Breast lesion localization is a process used to find these lesions. In the case of breast cancer, lesion localization devices must be used. The age of the patient, the typical travel time, the effectiveness of the procedure, the ease of usage, and safety are just a few of the factors that surgeons consider when choosing a course of treatment.

The market for breast lesion localization in 2021 was , and it will be worth USD 3038 million by 2030, growing at a 13.57% CAGR during the forecast period.

The market’s expansion is due to a sedentary lifestyle, an increase in breast cancer instances, rising pill usage, and an increase in the frequency of breast disease or breast cysts. The Breast Cancer Organization predicts that among women living in the United States in 2022, there will be a total of 287,850 new cases of invasive breast cancer.

Market Dynamics


The market is expanding primarily due to the rising cases of breast cancer globally. Per a report by WHO, approximately 2.3 million women were detected with breast cancer, and nearly 685,000 deaths occurred globally. Technology developments in breast lesion localization techniques and rising public awareness of early identification and treatment of breast cancer contribute to the market’s expansion. Additionally, the development of precise, affordable, and safe advanced gadgets assists in the expansion of the global market’s revenue.


There is a growing need for oncologists and other competent healthcare workers to handle the rising number of breast cancer cases that need to be treated and operated on. Furthermore, a major factor hampering market expansion is the lack of skilled oncologists in developing nations.


There are opportunities for market participants due to aggressive government investment in developing and modernization of healthcare infrastructure. Additionally, the market has favorable growth prospects due to ongoing technological developments and increased public awareness of breast cancer detection.

Market Segmentation 

By Technique

By technique, the market is segmented into radioisotope localization, wire localization, electromagnetic localization, magnetic localization, and others.

In 2021, the wire localization category dominated the market with a 32% type-based market share. Wire localization is a simple and affordable tool for radiologists and surgeons. These factors are causing the wire localization segment to grow since, in addition to processing, wire localization services offer a wide range of alternatives for quickly connecting to radiology imaging machines through a directed wire.

By Usage

The market is segmented into tumor identification, sentinel lymph node identification, and lumpectomy.

The tumor identification segment ruled the entire market in 2020 with USD 543.1 million. Furthermore, the sentinel lymph node identification segment will expand at a rapid rate due to the growing adoption of SLNB as a first-line diagnostic method for breast cancer staging.

By End-User

On the basis of end-user, the market is segmented into oncology clinics, diagnostic centers, hospitals, and others. 

The hospital segment will generate a revenue share of $596.2 million in terms of end users from 2021 to 2028. This market sector is expanding due to the increasing prevalence of breast cancer, the availability of qualified specialists, and the wide adoption of cutting-edge localization methods for breast lesions.

Regional Analysis 

In 2021, North America accounted for 35% of the revenue share. It is because established government programs for cancer screening are readily available, as are the reimbursement policies for the area. Most people with breast cancer live in the North American region, and the government is investing heavily in medical equipment and Breast Lesion Localization Devices. These elements are causing the Breast Lesion Localization Market in North American nations to expand.

Through the projection period, the European area will experience considerable growth at a CAGR of 9%. Breast cancer patients have become more prevalent in European nations due to rising breast cancer prevalence and the use of cutting-edge localization techniques for the disease’s treatment.

Key Players

  • Sirius Medical
  • Surgiceye GmbH
  • Elucent Medical
  • Hologic
  • Health Beacons
  • Leica Biosystems
  • Ranfac Corporation
  • Intra-Medical Imaging
  • Cook Medical
  • Cianna Medical
  • Laurane Medical
  • SOMATEX Medical Technologies GmbH
  • Endomagnetics
  • C.R. Bard
  • Molli Surgical
  • Sirius Medical BV
  • Tsunami Medical
  • Becton, Dickinson, and Company
  • IZI Medical Products
  • Mermaid Medical A/S
  • Argon Medical Devices

The market for breast lesion localization in 2021 was USD 966.56 million, and it will be worth USD 3038 million by 2030, growing at a 13.57% CAGR during the forecast period. Increased government and non-government reimbursement policies, increased public awareness of breast cancer diagnosis, and the development of novel technologies and techniques for the localization of breast cancer lesions are some reasons driving market expansion.

As per the Bosom Disease Association, it was assessed that in 2018, 266,120 new instances of obtrusive and 63,960 instances of harmless bosom malignant growth would be analyzed. Rising number of government and non-government repayment strategies for bosom malignant growth diagnostics, biopsy, and other related operations is assessed to support the reception of bosom injury limitation techniques.

Rising interest for better medical care framework and offices and expanding mindfulness level about bosom disease screening are additionally expected to support the market development. For example, public bosom disease screening program in Australia called the Bosom Screen Australia, which gives free mammogram test benefits like clockwork for ladies matured somewhere in the range of 50 and 74. Creating districts, like India and China, are additionally spreading mindfulness about early determination.

Also, presentation of mechanically progressed items on the grounds of precision, security, and cost-adequacy is considered as the high effect delivering factor for the bosom injury confinement techniques market. Organizations, like Endomagnetics and Cianna Inc. have fostered another scope of strategies individually chipping away at attractive and electroradar direction for limitation of bosom injuries. For example, SAVI SCOUT limitation innovation of Cianna Clinical, Inc. has performed north of 50,000-bosom cancer restriction in more than 375 emergency clinics across the U.S.